| K-number | K223405 |
| Device name | Access Testosterone |
| Applicant | Beckman Coulter, Inc. |
| Product code | CDZ |
| Device class | Class I |
| Decision date | Jan 13, 2023 |
| Decision | Substantially Equivalent |
| Regulation | 862.1680 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov